Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice

@article{Nakata2017DopamineSP,
  title={Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice},
  author={Y. Nakata and N. Kanahara and M. Iyo},
  journal={Journal of Psychopharmacology},
  year={2017},
  volume={31},
  pages={1511 - 1518}
}
  • Y. Nakata, N. Kanahara, M. Iyo
  • Published 2017
  • Medicine, Psychology
  • Journal of Psychopharmacology
  • Dopamine supersensitivity psychosis (DSP) is observed in patients with schizophrenia under antipsychotic treatment, and it is characterized by rebound psychosis, an uncontrollable psychotic episode following a stable state and tardive dyskinesia. DSP, first described in patients taking typical antipsychotics in the late 1970s, sometimes appears even in patients who are treated with current atypical antipsychotics. It was recently demonstrated that DSP can have a negative impact on the long-term… CONTINUE READING
    Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
    3
    CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4
    9
    Expression of Dopamine-Related Genes in Four Human Brain Regions

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 83 REFERENCES
    Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia
    6
    Supersensitivity Psychosis and Its Response to Asenapine in a Patient with Delusional Disorder
    3
    Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
    67